Dr. Joerns et al reply
We thank the authors<sup>1</sup> for their thoughtful and collegial response to our study<sup>2</sup> and for their interest in translating these epidemiologic findings into clinically actionable strategies. We are encouraged by their recognition of serostatus as a key prognostic factor in rheumatoid arthritis (RA)–associated respiratory mortality, and we appreciate the opportunity to clarify several methodological considerations.
Authors
- Elena Myasoedova (ORCID: https://orcid.org/0000-0003-2006-1436)
- Ryan J. Lennon (ORCID: https://orcid.org/0000-0002-8366-8422)
- Vanessa L. Kronzer (ORCID: https://orcid.org/0000-0002-7489-3134)
- Elena K. Joerns (ORCID: https://orcid.org/0000-0001-7089-9152)
- Roslin Jose George (ORCID: https://orcid.org/0009-0000-2697-3511)
- Cynthia S. Crowson
- John M. Davis
- Andrea Lopez-Ruiz
Institutions
- Mayo Clinic (US)
- Mayo Clinic in Arizona (US)
- Mayo Clinic in Florida (US)
Publication Details
- Journal
- The Journal of Rheumatology
- Published
- 2026-04-01
- DOI
- https://doi.org/10.3899/jrheum.2026-0122
- Primary Topic
- Rheumatoid Arthritis Research and Therapies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institutes of Health
- National Institute on Aging